About Us
Shaping the future of autoimmune testing.
We’re a global market leader in autoimmune diagnostics, delivering highly accurate reagents and highly efficient automation to labs throughout the world.
News
704575
QUANTA Lite® h-tTG/DGP Screen
This assay is designed for the detection of IgA and IgG antibodies to synthetic, deamidated gliadin-derived peptides (DGP) and human tissue transglutaminase (h-tTG) in human serum. The presence of these antibodies can be used to aid in the diagnosis of IgA sufficient and IgA deficient celiac disease as well as dermatitis herpetiformis.
IVD-In Vitro Diagnostic Use / CE marked
Technology
ELISA
CLIA complexity
High
Package Size
1 X 96 wells
Disease Area Application
Celiac Disease
Antigen Source
h-tTG Native (human red blood cell); DGP peptide (synthetic, deamidated)
Availability
Worldwide
Files & Resources
704575_Safety_Data_Sheet (English)
704575_CLSI (English)
Utility of the New ESPGHAN Criteria for the Diagnosis of Cel
Compatible Systems
QUANTA-Lyser® 160/240 EIA/IFA Processors
QUANTA-Lyser® 160/240 EIA/IFA Processors
Flexible EIA/IFA processing platform to meet the volume requirements of your laboratory
QUANTA-Lyser® 2
QUANTA-Lyser® 2
QUANTA-Lyser® 2 is the ideal platform for esoteric assays or in settings that require maximum flexibility and efficiency
QUANTA-Lyser® 3000
QUANTA-Lyser® 3000
QUANTA-Lyser 3000 is a high throughput EIA/IFA that give you the ability to complete your workload faster with less hands-on time.
Related Reagents
Contact us
Please contact us directly via email, telephone, or with the following form.
EMAIL:
support@inovadx.com
TOLL FREE PHONE:
800.545.9495
PHONE:
858.586.9900
FAX:
858.586.9911
